Last updated: January 30, 2024
Sponsor: Fundación EPIC
Overall Status: Active - Recruiting
Phase
N/A
Condition
Coronary Artery Disease
Hypertriglyceridemia
Cardiovascular Disease
Treatment
Essential pro
Clinical Study ID
NCT05292092
Essential Pro PMCF Study
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient treated with Essential Pro according to routine hospital practice andfollowing instructions for use
- Informed consent signed
Exclusion
Exclusion Criteria:
• Not meet inclusion criteria
Study Design
Total Participants: 176
Treatment Group(s): 1
Primary Treatment: Essential pro
Phase:
Study Start date:
September 26, 2022
Estimated Completion Date:
March 30, 2025
Study Description
Connect with a study center
Hospital Punta de Europa
Algeciras, 11207
SpainActive - Recruiting
Hospital Clinic de Barcelona
Barcelona, 08036
SpainActive - Recruiting
Hospital Universitario de Jerez de la Frontera
Jerez De La Frontera, 11407
SpainActive - Recruiting
Hospital Universitario de Leon
León, 24080
SpainActive - Recruiting
Hospital Universitario Regional de Malaga
Málaga, 29010
SpainActive - Recruiting
Hospital Universitario de Puerto Real
Puerto Real, 11510
SpainActive - Recruiting
Hospital Universitario Marques de Valdecilla
Santander, 39008
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.